Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pricing Concerns Delaying Sanofi’s Turkey Insulin Investment?

Executive Summary

Despite the political turmoil, Sanofi appears keen to invest in the local manufacturing of an insulin product in Turkey if the government “opens the way”, but is holding off over pricing worries.

You may also be interested in...

Turkey Jostles For Slice Of Biologics Manufacturing Pie

Many local pharma companies in Turkey have been launching capital investments in new production facilities for biologics and biosimilars in the hope of attracting new foreign partners and have already met with some success, but a number of obstacles remain.

Turkey Company Roundup: Roche Case Reopens, Sanofi Starts Exports

The Supreme Court in Turkey has cancelled a statute of limitations decision in a Roche legal case, with some ex-managers and bureaucrats to be retried. Meanwhile, Sanofi Turkey has become the first pharmaceutical company to export antibiotics to Japan from a production site in Turkey, the AIFD has elected a chairman, and Lilly has made new appointments.

Turkey’s $2.6Bn Hospital Medtech Debts Create Problems On Top Of COVID-19

Turkey’s efforts to control rising rates of COVID-19 are compromising the ability of hospitals to pay their debts to medtech and pharmaceutical companies. The government has devised a payments plan, but there is catch.


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts